Diamedica Therapeutics Inc (DMAC)

Jan 22, 2026

Cantor Fitzgerald reiterates Overweight rating on DiaMedica stock - Investing.com

Jan 22, 2026

Jan 21, 2026

Aug Final Week: Whats next for CWAN stockJuly 2025 Update & Daily Volume Surge Trade Alerts - baoquankhu1.vn

Jan 21, 2026

Jan 19, 2026

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com

Jan 19, 2026

Jan 19, 2026

What technical charts say about DiaMedica Therapeutics Inc. stock2025 Volume Leaders & Free Expert Approved Momentum Trade Ideas - bollywoodhelpline.com

Jan 19, 2026

Jan 18, 2026

Short Interest in DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Declines By 22.8% - MarketBeat

Jan 18, 2026

Jan 16, 2026

DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal

Jan 16, 2026

Jan 14, 2026

DiaMedica Therapeutics raises capital via share offering - MSN

Jan 14, 2026

Jan 13, 2026

Trading Action: Why DiaMedica Therapeutics Inc. stock is a value investor pickWeekly Profit Analysis & Low Risk Entry Point Tips - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Jan 13, 2026

Jan 13, 2026

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Jan 13, 2026

Jan 12, 2026

Nasdaq Moves: Is DiaMedica Therapeutics Inc a cyclical or defensive stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn

Jan 12, 2026

Jan 10, 2026

Panic Selling: Can DiaMedica Therapeutics Inc. stock surprise with earnings upsideQuarterly Portfolio Summary & Safe Entry Momentum Stock Tips - Улправда

Jan 10, 2026

Jan 10, 2026

DiaMedica Therapeutics (NASDAQ:DMAC) Stock Price Down 2.3%Should You Sell? - MarketBeat

Jan 10, 2026

Jan 08, 2026

Why DiaMedica Therapeutics Inc. stock is a value investor pickRecession Risk & Daily Technical Forecast Reports - ulpravda.ru

Jan 08, 2026

Jan 05, 2026

DiaMedica Therapeutics (DMAC) Seen as Strong Performer with Upco - GuruFocus

Jan 05, 2026

Jan 05, 2026

DiaMedica Therapeutics Inc.Common Stock (NQ: DMAC - FinancialContent

Jan 05, 2026

Jan 05, 2026

DiaMedica Therapeutics sells 1.5 million shares in $12.2 million block trade By Investing.com - Investing.com Nigeria

Jan 05, 2026

Jan 05, 2026

DiaMedica Therapeutics Raises Capital via Share Offering - TipRanks

Jan 05, 2026

Jan 05, 2026

DiaMedica Therapeutics sells 1.5 million shares in $12.2 million block trade - Investing.com

Jan 05, 2026

Dec 25, 2025

A US$59m Drop in the Market Cap of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Is Not What Insiders Like to See After Purchasing Shares Recently - 富途牛牛

Dec 25, 2025

Dec 22, 2025

DiaMedica Therapeutics (DMAC) price target increased by 25.68% to 15.81 - MSN

Dec 22, 2025

Dec 21, 2025

Can DiaMedica Therapeutics Inc. stock surprise with earnings upsideTrade Analysis Summary & Growth Focused Stock Pick Reports - Улправда

Dec 21, 2025

Dec 21, 2025

Craig-Hallum Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC) - The Globe and Mail

Dec 21, 2025

Dec 20, 2025

DiaMedica Therapeutics provides DM199 update following FDA meeting - MSN

Dec 20, 2025

Dec 20, 2025

Why DiaMedica Therapeutics Inc. stock attracts high net worth investorsGold Moves & Low Volatility Stock Suggestions - Улправда

Dec 20, 2025

Dec 20, 2025

Is DiaMedica Therapeutics Inc. stock in correction or buying zone2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - Улправда

Dec 20, 2025

Dec 19, 2025

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

Dec 19, 2025

Dec 19, 2025

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 19, 2025

Dec 18, 2025

After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - Nasdaq

Dec 18, 2025

Dec 18, 2025

DiaMedica (DMAC) Advances with FDA in Preeclampsia Study Plans - GuruFocus

Dec 18, 2025

Dec 18, 2025

DiaMedica Says FDA Seeks Additional Study Ahead of Pre-IND Submission for Preeclampsia Treatment - marketscreener.com

Dec 18, 2025

Dec 18, 2025

DiaMedica to conduct additional study for preeclampsia treatment - Investing.com

Dec 18, 2025

Dec 18, 2025

DiaMedica to conduct additional study for preeclampsia treatment By Investing.com - Investing.com Canada

Dec 18, 2025

Dec 18, 2025

Diamedica Therapeutics provides DM199 preeclampsia program update - marketscreener.com

Dec 18, 2025

Dec 18, 2025

DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting - TipRanks

Dec 18, 2025

Dec 18, 2025

DiaMedica Therapeutics Inc Provides DM199 Preeclampsia Program Update - TradingView — Track All Markets

Dec 18, 2025

Dec 18, 2025

DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA - The AI Journal

Dec 18, 2025

Dec 18, 2025

[8-K] DiaMedica Therapeutics Inc. Reports Material Event | DMAC SEC FilingForm 8-K - Stock Titan

Dec 18, 2025

Dec 15, 2025

DiaMedica Therapeutics Earnings Notes - Trefis

Dec 15, 2025

Dec 13, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 7.4%Here's Why - MarketBeat

Dec 13, 2025

Dec 12, 2025

DiaMedica Therapeutics Inc (DMAC) Stock News & Articles - 24/7 Wall St.

Dec 12, 2025

Dec 11, 2025

Top investors say DiaMedica Therapeutics Inc (DMAC) ticks everything they need - setenews.com

Dec 11, 2025

Dec 10, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Sets New 1-Year HighTime to Buy? - MarketBeat

Dec 10, 2025

Dec 10, 2025

Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA) and Diamedica Therapeutics (DMAC) - The Globe and Mail

Dec 10, 2025

Dec 09, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Purchases 182,882 Shares of Stock - Defense World

Dec 09, 2025

Dec 09, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Major Shareholder Jan Stahlberg Buys 187,393 Shares of Stock - Defense World

Dec 09, 2025